Autopsy report · NCT00815386
Safety and Efficacy Study of the PTMA Device to Reduce Mitral Valve Regurgitation in Patients With Heart Failure
Cause of deathOther
“Company ended operations in January 2011”
Life of this trial
- Registered 2 months before it started.
- Suspended: paused, and may or may not restart.
- 20 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2, Phase 3
- Sponsor
- Viacor
- Sponsor type
- Industry
- Conditions
- Mitral Regurgitation; Heart Failure
- Interventions
- Percutaneous transvenous mitral annuloplasty
- Participants
- 20 (planned, not actual)
- Sites
- 3
- Countries
- Canada
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.